VIVOBIOT logo

VIVO BIO TECH LTD.

VIVOBIOT·BSE·
18.99 +0.29 (+1.55%)
Market Cap56.17 Cr
PE Ratio4.48
Volume13,030
Day High - Low19.38 - 18.32
52W High-Low20.94 - 17.51
DocStoX Score
5.2/10
Weak
Fair Value
Sign in to see
ROE
9.30%
Average
P/E
4.48x
Cheap
Debt / Equity
0.72
Moderate
Industry
Healthcare
Biotechnology
Overall View
Mixed

Price performance

Day18.32
19.38
52W17.51
20.94
DocStoX take

Supported by valuation (9.0) and quality (6.7), but held back by growth (1.0). Valuation looks strong at 9.0, but that is offset by growth at 1.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.2
/10
Weak
Quality
Solid
ROE 9.3%
Valuation
Cheap
P/E 4.5×
Growth
Flat
Revenue +0.6% 5Y CAGR
Risk
Moderate
D/E 0.72
Momentum
Soft
43% of 52-week range

At a glance

Market Cap
₹56 Cr
52W High / Low
₹21 / ₹18
Dividend Yield
0.00%
Promoter Holding
30.62%
EPS (TTM)
₹4.24
Book Value
₹41.25

Key highlights

  • Profitable in all of the last 5 years
  • Undemanding at 4× earnings
  • Healthy net margin (16%)
  • Profit shrinking 7% a year
  • Growth is weak (1.0/10)
3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Biotechnology

VIVO BIO TECH LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.